Bottled Sodium Chloride Injection Market

Sodium Chloride Injection, which is mostly the 0.9% sodium chloride water, also called as normal saline. It is a colorless, clear liquid. And it is sterile and no pyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. Main ingredient of sodium chloride injection is sodium chloride. Sodium chloride is an electrolysis supplement agent. Sodium and chloride are important electrolysis for the human body and mainly exist in extracellular fluid, which play an important role in maintaining normal volume of blood, and extracellular fluid and osmosis pressure.

Bottled Sodium Chloride Injection Market contains market size and forecasts of Bottled Sodium Chloride Injection in global, including the following market information:

Global Bottled Sodium Chloride Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Bottled Sodium Chloride Injection Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five Bottled Sodium Chloride Injection companies in 2021 (%)

The global Bottled Sodium Chloride Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Plastic Bottle Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bottled Sodium Chloride Injection include Baxter, Kelun Group, Fresenius Kabi, BBraun, Shijiazhuang No.4 Pharmaceutical, Hospira (ICU Medical), CR Double-Crane, Otsuka and Cisen Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Bottled Sodium Chloride Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bottled Sodium Chloride Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Bottled Sodium Chloride Injection Market Segment Percentages, by Type, 2021 (%)

• Plastic Bottle
• Glass Bottle

Global Bottled Sodium Chloride Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Bottled Sodium Chloride Injection Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Bottled Sodium Chloride Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Bottled Sodium Chloride Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Bottled Sodium Chloride Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Bottled Sodium Chloride Injection revenues share in global market, 2021 (%)
• Key companies Bottled Sodium Chloride Injection sales in global market, 2017-2022 (Estimated), (K MT)
• Key companies Bottled Sodium Chloride Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Baxter
• Kelun Group
• Fresenius Kabi
• BBraun
• Shijiazhuang No.4 Pharmaceutical
• Hospira (ICU Medical)
• CR Double-Crane
• Otsuka
• Cisen Pharmaceutical
• Huaren Pharmaceuticals
• Dubang Pharmaceutical
• Zhejiang Chimin
• Guizhou Tiandi
• Qidu Pharmaceutical